Response to Cherella et al. re: “The Use of the Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: A Meta-Analysis”

Cherella CE, Cibas ES, Wassner AJ 2021 Re: “The use of the Bethesda System for Reporting Thyroid Cytopathology in pediatric thyroid nodules: a meta-analysis” by Vuong et al. Thyroid 31:1441–1442.

Vuong HG , Chung DGB , Ngo LM , Bui TQ , Hassell L , Jung CK , et al. 2021. The use of the Bethesda System for Reporting Thyroid Cytopathology in pediatric thyroid nodules: A meta-analysis. Thyroid, 31:1203–1211.

Faquin WC , Wong LQ , Afrogheh AH , Ali SZ , Bishop JA , Bongiovanni M , et al. 2016. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol, 124:181–187.

Cherella CE , Angell TE , Richman DM , Frates MC , Benson CB , Moore FD , et al. 2019. Differences in thyroid nodule cytology and malignancy risk between children and adults. Thyroid, 29:1097–1104.

Cibas ES , Ali SZ . 2017. The 2017 Bethesda System for reporting thyroid cytopathology. Thyroid, 27:1341–1346.

Vuong HG , Ngo HTT , Bychkov A , Jung CK , Vu TH , Lu KB , et al. 2019. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: a systematic review and meta-analysis. Cancer Cytopathol, 128:238–249.